moxifloxacin has been researched along with Adverse Drug Event in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 6 (46.15) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
| Bastogne, T; Champéroux, P; Fares, R; Le Guennec, JY; Richard, S; Thireau, J | 1 |
| De-La-Torre, A; Gutiérrez, NM; Muñoz-Ortiz, J; Peñaranda-Henao, M; Reyes-Guanes, J | 1 |
| Alexander, VJ; Balogh, K; Geary, RS; Hurh, E; Karwatowska-Prokopczuk, E; O'Dea, L; Tsimikas, S; Watts, LM | 1 |
| Bonate, PL | 1 |
| Bucsa, C; Farcas, A; Huruba, M; Leucuta, DC; Mogosan, C; Sipos, M | 1 |
| Abd Hamid, MR; Ramli, N; Tai, ELM; Wan Hazabbah, WH | 1 |
| Benson, C; Brown, R; Couderc, JP; Darpo, B; Dota, C; Ferber, G; Ferry, J; Jarugula, V; Keirns, J; Ortemann-Renon, C; Pham, T; Riley, S; Sarapa, N; Ticktin, M; Zareba, W | 1 |
| Jiang, RH; Li, L; Xu, HB | 1 |
| Budnitz, DS; Jones, SC; Mehta, H; Sorbello, A | 1 |
| Vos, MA | 1 |
| Andersen, MP; Graff, C; Kanters, JK; Matz, J; Nielsen, J; Struijk, JJ; Toft, E | 1 |
| Alder, J; Arvis, P; De Waele, JJ; Hampel, B; Jensen, M; Reimnitz, P; Tellado, JM | 1 |
1 review(s) available for moxifloxacin and Adverse Drug Event
| Article | Year |
|---|---|
Literature-based evaluation of four 'hard endpoint' models for assessing drug-induced torsades de pointes liability.
Topics: Animals; Aza Compounds; Cisapride; Dogs; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Fluoroquinolones; Humans; Models, Biological; Moxifloxacin; Quinolines; Rabbits; Risk Assessment; Terfenadine; Torsades de Pointes | 2008 |
4 trial(s) available for moxifloxacin and Adverse Drug Event
| Article | Year |
|---|---|
Treatment with Volanesorsen, a 2'-O-Methoxyethyl-Modified Antisense Oligonucleotide Targeting
Topics: Adult; Apolipoprotein C-III; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Female; Healthy Volunteers; Humans; Hypertriglyceridemia; Male; Moxifloxacin; Oligonucleotides; Oligonucleotides, Antisense; Placebo Effect; RNA, Messenger; Triglycerides | 2020 |
Evaluation of the Effect of 5 QT-Positive Drugs on the JTpeak Interval - An Analysis of ECGs From the IQ-CSRC Study.
Topics: Arrhythmias, Cardiac; Biomarkers; Cetirizine; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Female; Fluoroquinolones; Healthy Volunteers; Heart Conduction System; Heart Rate; Humans; Indoles; Ion Channels; Long QT Syndrome; Male; Moxifloxacin; Ondansetron; Phenethylamines; Quinine; Quinolizines; Risk Assessment; Sulfonamides | 2020 |
Covariate analysis of QTc and T-wave morphology: new possibilities in the evaluation of drugs that affect cardiac repolarization.
Topics: Adolescent; Adult; Algorithms; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Aza Compounds; Cardiovascular Agents; Data Interpretation, Statistical; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Female; Fluoroquinolones; Heart; Humans; Male; Middle Aged; Moxifloxacin; Quinolines; Risk Assessment; Sotalol; Torsades de Pointes; Young Adult | 2010 |
Randomised clinical trial of moxifloxacin versus ertapenem in complicated intra-abdominal infections: results of the PROMISE study.
Topics: Administration, Intravenous; Adult; Aged; Anti-Bacterial Agents; Aza Compounds; beta-Lactams; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Ertapenem; Female; Fluoroquinolones; Humans; Incidence; Intraabdominal Infections; Male; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Treatment Outcome | 2013 |
8 other study(ies) available for moxifloxacin and Adverse Drug Event
| Article | Year |
|---|---|
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
Contribution of haemodynamic side effects and associated autonomic reflexes to ventricular arrhythmias triggering by torsadogenic hERG blocking drugs.
Topics: Animals; Arrhythmias, Cardiac; Dogs; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Ether-A-Go-Go Potassium Channels; Heart Rate; Long QT Syndrome; Moxifloxacin; Quinidine; Reflex; Torsades de Pointes | 2022 |
Anterior Uveitis Due to Intracameral Moxifloxacin: A Case Report.
Topics: Anterior Chamber; Anti-Bacterial Agents; Cataract Extraction; Diagnosis, Differential; Drug-Related Side Effects and Adverse Reactions; Endophthalmitis; Exfoliation Syndrome; Eye Pain; Gonioscopy; Humans; Male; Middle Aged; Moxifloxacin; Ocular Hypertension; Photophobia; Uveitis, Anterior | 2021 |
The application of extreme value theory to pharmacometrics.
Topics: Acetanilides; Cross-Over Studies; Data Interpretation, Statistical; Datasets as Topic; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Female; Heart Rate; Humans; Male; Minimal Clinically Important Difference; Models, Biological; Moxifloxacin; Pharmacology, Clinical; Placebos; Randomized Controlled Trials as Topic; Thiazoles | 2021 |
A VigiBase descriptive study of fluoroquinolone induced disabling and potentially permanent musculoskeletal and connective tissue disorders.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Adverse Drug Reaction Reporting Systems; Arthralgia; Ciprofloxacin; Connective Tissue Diseases; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Musculoskeletal Diseases; Myalgia; Norfloxacin; Ofloxacin; Pain; Risk Factors; Tendinopathy; Tendons; Young Adult | 2021 |
Vernal Keratoconjunctivitis-When Medication Fails.
Topics: Asthma; Child; Conjunctivitis, Allergic; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Moxifloxacin; Ophthalmic Solutions; Recovery of Function; Treatment Failure; Vision, Ocular; Withholding Treatment | 2019 |
Comparative roles of moxifloxacin and levofloxacin in the treatment of pulmonary multidrug-resistant tuberculosis: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Aza Compounds; China; Drug-Related Side Effects and Adverse Reactions; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Quinolines; Recurrence; Retrospective Studies; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult | 2013 |
US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactions.
Topics: Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Drug-Related Side Effects and Adverse Reactions; Emergency Service, Hospital; Female; Fluoroquinolones; Humans; Hypersensitivity; Levofloxacin; Male; Middle Aged; Moxifloxacin; Quinolines; United States | 2013 |